Monica Doerr, MD
Endocrinology, Diabetes & Metabolism · High Point, NCNPI 1952337271
Payments from drug & device makers
Across 438 payments — averaging $25.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- Lilly USA, LLC$2K
- Bayer$795
- Abbott$601
- Mannkind Corporation$573
- Boehringer Ingelheim$566
- plus $4K from 33 others
What the payments were for
- Consulting fees$1,62014%
- Food & beverage$9,57285%
- Education$691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 90 | $2,935 |
| Lilly USA, LLC | 75 | $1,716 |
| Bayer | 22 | $795 |
| Abbott | 30 | $601 |
| Mannkind Corporation | 35 | $573 |
| Boehringer Ingelheim | 24 | $566 |
| Amgen | 21 | $470 |
| Medtronic(2 entities) | 12 | $447 |
| AstraZeneca(2 entities) | 13 | $333 |
| AbbVie | 13 | $317 |
| Sanofi-aventis U.S. LLC | 14 | $315 |
| Cequr Corporation | 3 | $305 |
| Xeris Pharmaceuticals, Inc. | 7 | $199 |
| Tandem Diabetes Care, Inc. | 3 | $192 |
| Dexcom, Inc. | 9 | $190 |
| Esperion Therapeutics, Inc. | 5 | $190 |
| Radius Health, Inc. | 11 | $181 |
| GSK | 4 | $172 |
| Merck | 10 | $154 |
| Lifescan, Inc. | 4 | $61 |
| Novartis | 3 | $51 |
| Antares Pharma, Inc. | 3 | $50 |
| Amarin Pharma, Inc. | 4 | $50 |
| Insulet Corporation | 2 | $49 |
| Amneal Pharmaceuticals LLC | 3 | $48 |
| IBSA Pharma Inc. | 3 | $42 |
| Tolmar, Inc. | 2 | $36 |
| Mylan Specialty L.p. | 1 | $32 |
| Acerus Pharmaceuticals Corporation | 2 | $31 |
| Sequel Med Tech, LLC | 1 | $23 |
| Nevro Corp. | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Rhythm Pharmaceuticals, Inc. | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Zealand Pharma US, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Intuity Medical Inc | 1 | $13 |
| Senseonics, Incorporated | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$1,620
- Kerendia$371
- CeQur Simplicity$289
- MOUNJARO$241
- JARDIANCE$240
- FREESTYLE LIBRE 3$150
- Minimed 630G$134
- NEXLIZET$123
- NEXLETOL$123
- FARXIGA$122
- AREXVY$122
- Synthroid$120
- Macrilen$120
- EVENITY$120
- Guardian Connect$111
- t-slim insulin pump$105
- BAQSIMI$100
How this compares
$11,261 in reported general payments places this provider in the 70th percentile of 232 endocrinology, diabetes & metabolism providers in North Carolina.
See all endocrinology, diabetes & metabolism providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KorlymMifepristone | 13 | $435,271 |
| OzempicSemaglutide | 343 | $395,779 |
| Tresiba Flextouch U-200Insulin Degludec | 135 | $189,400 |
| TrulicityDulaglutide | 138 | $168,958 |
| MounjaroTirzepatide | 76 | $104,707 |
| JardianceEmpagliflozin | 95 | $89,432 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 75 | $86,314 |
| Humalog Kwikpen U-200Insulin Lispro | 57 | $75,762 |
| RybelsusSemaglutide | 50 | $54,171 |
| Novolog FlexpenInsulin Aspart | 129 | $43,419 |
| Tresiba Flextouch U-100Insulin Degludec | 75 | $42,526 |
| FarxigaDapagliflozin Propanediol | 39 | $39,663 |
| TymlosAbaloparatide | 14 | $37,405 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 47 | $36,284 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 32 | $35,906 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $2,935 | $455,213408 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $1,716 | $277,329227 claims |
| Boehringer IngelheimJardiance, Tradjenta, Glyxambi | $566 | $107,849129 claims |
| MerckJanuvia, Janumet Xr | $154 | $40,76053 claims |
| AstraZenecaFarxiga | $333 | $39,66339 claims |
| Radius Health, Inc.Tymlos | $181 | $37,40514 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $315 | $29,79344 claims |
| AbbVieSynthroid | $317 | $4,30149 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $48 | $2,492294 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 232 endocrinology, diabetes & metabolism providers in North Carolina.
Other endocrinology, diabetes & metabolism in High Point
- Kathryn LucasMorehead City$37.9M
- Mark WarrenGreenville$5M
- Mary LawrenceMorehead City$4.9M
- John ParkerWilmington$4.1M
- John BuseChapel Hill$3.8M
- Wendy LaneAsheville$1.9M
- Anthony BarberHickory$1.4M
- Klara KleinChapel Hill$1.3M
- Thomas OconnellBurlington$805K
- Corey BerlinRaleigh$742K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.